[Diagnosis and treatment of pancreatic @entity3 from XXXX ].

@entity1 @entity353 @entity1087 @entity5 @entity1358 @entity3 @entity490
OBJECTIVE: Pancreatic @entity3 from @entity1358 ( @entity1358 ) is a rare event and has not been reported in our country. We report a series of 3 @entity1 with metastatic @entity1358 to the pancreas after radical nephrectomy at our institution. The published reports in the literature were reviewed, and the diagnosis, treatment as well as prognosis of this rare event were discussed. METHODS: The data of 3 @entity1358 @entity1 with @entity3 to the pancreas were reviewed retrospectively, including radical nephrectomy, metastatic interval, the second and third surgical removal. Survival of the three @entity1 was analyzed and the reports in the literature were compared as well. RESULTS: The average interval from radical nephrectectomy to the comfirmed pancreatic @entity3 was 6.6 years (range, 1.2 to 12 years). The pathological stage revealed T2N0M0 (n = 2) or T3N0M0 (n = 1), with right-sided @entity5 in 2 @entity1 and left side in 1. One @entity1 was asymptomatic, while the other two cases were symptomatic at presentation, including upper @entity490 , @entity353 , slight xanthochromia of the skin and titillation, clay stool (n = 1); irregular fever, @entity353 and @entity1087 (n = 1). All pancreatic @entity3 were hypervascular on arterial stage of CT imaging. One @entity1 had only a solitary pancreatic @entity3 (n = 1), the another showed two metastatic lesions (n = 1), the third one had multiple lesions (n = 1). Surgical removal was accomplished in 2 @entity1 : including pylorus-preserving pancreaticoduodenectomy in one, and pylorus-preserving pancreaticoduodenectomy together with partial tail resection in another one. The third one only received interventional therapy due to widespread extrapancreatic @entity3 , and died of disseminated disease 11 months after the therapy. One of the above two surgically treated @entity1 underwent the second removal due to local recurrence 2.5 years after the first removal of pancreatic @entity3 . These two @entity1 were still alive after follow-up of 8.6 years and 16.1 years, respectively. CONCLUSION: @entity1358 is an unpredictable @entity5 that may demonstrate very delayed @entity3 even from early-stage of the disease. The pancreas is a rare site of @entity3 from @entity1358 . We advocate careful long-term follow-up of @entity1 with a history of @entity1358 . Aggressive surgical management of pancreatic metastatic lesions may provide a chance of long-term survival.
